Helen of Troy Ltd

HELE

Equity

ISIN BMG4388N1065 / Valor 938381

NASDAQ (2025-11-17)

USD 17.55-5.14%

Helen of Troy Ltd
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Helen of Troy Limited is a global consumer products company that designs, manufactures, and markets a diverse portfolio of well-known brands across various sectors, including health and wellness, beauty, and home care. The company integrates tax efficiency into its commercial operations, ensuring compliance with relevant laws while supporting business decision-making processes. By proactively managing tax risks and incorporating tax considerations into business proposals, Helen of Troy aims to optimize its financial performance and maintain robust governance. The company's strategic approach to tax affairs is overseen by its Board of Directors, ensuring that financial strategies align with overall business objectives and are regularly reviewed to adapt to changing regulatory environments.

Summarized from source with an LLMView SourceSector: Healthcare

Net Sales Decline

Consolidated net sales decreased by 10.8% to $371.7 million compared to the same period last year, primarily driven by a $71.0 million decline in the organic business. This decline was partially offset by the acquisition of Olive & June, contributing $26.8 million to net sales.

Operating Loss

The company reported an operating loss of $407.0 million, representing 109.5% of net sales. This loss was mainly due to non-cash asset impairment charges of $414.4 million and increased selling, general, and administrative expenses.

Earnings Per Share

Helen of Troy Ltd reported a GAAP diluted loss per share of $19.65, compared to diluted earnings per share of $0.26 in the previous year. On a non-GAAP adjusted basis, diluted earnings per share were $0.41, down from $0.99.

Cash Flow

Cash flow from operations was $58.3 million, while free cash flow stood at $45.0 million, reflecting the company's ability to generate cash despite the revenue decline.

Second Quarter Outlook

The company provided guidance for the second quarter fiscal 2026, anticipating consolidated net sales between $408 million and $432 million and adjusted diluted earnings per share ranging from $0.45 to $0.60.

Summarized from source with an LLMView Source

Key figures

-73.0%1Y

-82.7%3Y

-91.2%5Y

Performance

72.1%1Y

58.4%3Y

50.4%5Y

Volatility